WALTHAM, Mass., July 10 /PRNewswire/ — According to Millennium Research Group’s Global Markets for Hysterectomy Alternatives 2008 report, which covers global endometrial ablation (GEA) devices, uterine artery embolization (UAE) devices, hysteroscopes, and endometrial resection devices, the global hysterectomy market will generate more than $700 million in 2012, primarily driven by expanding GEA procedure volumes.
In the US and UK, the availability of a sufficient level of reimbursement has facilitated gynecologist adoption of GEA and, as a result, the procedure has become the gold standard for treating menorrhagia, an abnormally heavy menstrual period. The lack of adequate reimbursement, on the other hand, has stunted GEA market growth in France, Germany, and Italy.
In the US, the number of GEA procedures performed in physician offices will continue to expand over the next five years. This shift will occur because reimbursement levels for in-office GEA procedures will make these treatments lucrative for physicians. Furthermore, physicians can perform a higher volume of procedures in-office because they do not face the same competition for operating room space that they may encounter in hospitals. In- office growth will be further aided by the efforts of various suppliers to provide extensive support to doctors who wish to adopt the procedure.
“Suppliers are providing more treatment advice, promoting the procedure through advertising, and helping doctors to improve their business management so that use of GEA will be profitable for them,” says Barbara Prud’homme, Senior Analyst at Millennium Research Group. “The number of facilities performing GEA procedures will also grow in the US, increasing patient accessibility to the treatment.”
The Global Markets for Hysterectomy Alternatives 2008 report provides coverage of all key industry competitors, including Hologic, Gynecare, Boston Scientific, KARL STORZ, and American Medical Systems. The report also includes data on the US, European (France, Germany, Italy, UK), and Japanese markets.
About Millennium Research Group
Millennium Research Group (http://www.mrg.net/), a Decision Resources, Inc. company (http://www.decisionresources.com/), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized consulting services.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
Millennium Research Group
CONTACT: Amy Krohn of Millennium Research Group, +1-416-364-7776 x101,[email protected]
Web site: http://www.mrg.net/http://www.decisionresources.com/
Comments